GV, formerly Google Ventures, has been a prominent investor in behavioral health over the last decade. Historically, much of the venture funding in digital mental health focused on wellness apps and solutions for mild mental health conditions such as stress, anxiety, and sleep improvement. However, GV is now turning its attention to more complex, high-impact areas: serious mental illness (SMI) and value-based care. This strategic shift highlights GV serious mental illness investment as a growing priority within the behavioral health sector.
In 2021 alone, digital mental health companies raised a record $5.5 billion in venture capital. While most early funding targeted low-acuity conditions, startups are now increasingly focused on acute, clinically complex conditions—an area of particular interest to GV’s Dr. Ben Robbins, a trained psychiatrist who was recently promoted to general partner. “It seems like we moved from what I think of as sort of consumer models of mental health care into low-acuity, clinical models around depression and anxiety,” Robbins explains. “Really in the last year or so, we’ve seen a whole bunch of activity in areas that I find really interesting, as a psychiatrist.” This momentum has fueled GV serious mental illness investment, signaling a new era for innovation in the space.
Serious Mental Illness The Need for Hybrid Care Models
Dr. Robbins notes that SMI presents unique challenges that make fully virtual care insufficient. Patients often face cognitive impairments, social complexities, and co-occurring medical conditions. “You can’t have only content or only a lightweight chatbot,” he says. “I don’t think that this is a space that’s really conducive to pure virtual. The combination of cognitive impairment, the social complexity, the clinical complexity – I think that pretty much has to be a hybrid model, if not fully in person.”
GV has a history of investing in both digital and brick-and-mortar companies, including Headway, Brightline, and Quartet Health. With more than $8 billion in assets under management and over $1.2 billion deployed into healthcare and life sciences since 2020, GV serious mental illness investment is gaining increased attention. “I think there’s a lot of work to be done around how to build a better health care system,” Robbins adds. “We’re super comfortable with brick-and-mortar-based investments. I love the idea of more hybrid care.”
The economic case for SMI investment is strong. Research from the Substance Abuse and Mental Health Services Administration estimates the lifetime burden per SMI patient at $3 million. Startups are experimenting with innovative operational models that combine clinical expertise, outreach, and technology to bridge gaps in care. Mobile clinics and proactive engagement efforts are among the strategies fueling GV serious mental illness investment, helping reach patients who are not already connected to healthcare systems.
Bridging Gaps in Care
Federally funded community health centers can provide high-quality care to patients who actively seek help, but many individuals with SMI remain disengaged from treatment. Mobile clinics, community outreach, and peer support networks are emerging as promising solutions. Companies like firsthand leverage peer networks to engage patients and bring them into care, reflecting the types of initiatives that align with GV serious mental illness investment.
“Really in the last year or so, we’ve seen a whole bunch of activity in areas that I find really interesting, as a psychiatrist,” Robbins emphasizes, highlighting the growing momentum in hybrid, community-based approaches. Federal initiatives, like the recent CMS ruling promoting community-based medication-assisted treatment for opioid use disorder, further support the expansion of decentralized, accessible care.
Value-Based Care A Key Focus
Alongside SMI, GV is emphasizing value-based care in behavioral health. Value-based care aims to improve patient outcomes while controlling costs, shifting away from fee-for-service models. “We spend most of our time in value-based care, and things that can enable value-based care,” Robbins notes. “We’re spending a ton of our time just taking a step back and figuring out what has actually shown promise, because it seems like almost nothing has shown an ability to provide high-quality care and reduce cost, despite a lot of investment and experimenting.”
Reducing hospitalization rates for patients with both behavioral and physical health needs is a key strategy. Intensive outpatient programs (IOPs) and partial hospitalization programs (PHPs) fill a critical gap, offering structured, full-day care for several weeks. Robbins explains, “IOPs and PHPs are super interesting just because of the tremendous need. You have outpatient providers that don’t have a way to escalate care short of sending people to the ED. You have an ED that has a 7- to 10-day wait. People are literally in the waiting rooms for weeks. So this idea that you can have a sort of scaled middle ground, where it’s not a locked inpatient unit, not just outpatient, you are seeing somebody all day, every day for a couple of weeks.”
Integrating Physical and Mental Health
Patients with SMI frequently experience comorbid conditions like diabetes and heart disease, increasing medical costs and complicating care. Value-based behavioral health models that integrate physical and mental health offer the potential to improve outcomes while controlling expenses. “You can do value-based care that focuses on medical costs, but then mental health quality,” Robbins notes.
Measuring outcomes remains challenging. Surveys adapted from clinical research are often used as quality metrics, but they may not fully capture the impact of care. Robbins emphasizes, “Delivering great care, I think it’s currently within the scope … of things that we can do. But the idea of measuring, I’m not sure we’re all that close, and so I would love to find ways that we can actually measure high quality care.”
The Road Ahead
GV serious mental illness investment reflects a larger trend in behavioral health: moving beyond wellness apps and light-touch solutions toward comprehensive, patient-centered care. Startups are exploring hybrid care models, mobile clinics, peer support networks, IOPs, and PHPs, while GV is providing capital and strategic guidance to help these models scale.
As Dr. Robbins notes, “In the world of behavioral health, I and the team are super interested in figuring out how we deliver great care, and how we measure it.” With this focus, GV serious mental illness investment is positioned to drive meaningful innovation, bridging gaps in access and creating value for both patients and the broader healthcare system. The next decade promises transformative advances in mental health care, fueled by strategic investment and a commitment to hybrid, outcomes-driven models.
